AKBAAkebia Therapeutics, Inc.May 7, 2026Q1 2026
Read transcript →Akebia Therapeutics, Inc. (AKBA) Earnings Call Transcripts
NASDAQ·Healthcare·Biotechnology
$0.66
—
Mkt Cap $162.19M
AKBAAkebia Therapeutics, Inc.May 7, 2026AKBAAkebia Therapeutics, Inc.Feb 26, 2026Q4 2025
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 10, 2025Q3 2025
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 7, 2025Q2 2025
Read transcript →AKBAAkebia Therapeutics, Inc.May 8, 2025Q1 2025
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 13, 2025Q4 2024
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 7, 2024Q3 2024
Read transcript →AKBAAkebia Therapeutics, Inc.May 9, 2024Q1 2024
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 8, 2023Q3 2023
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 25, 2023Q2 2023
Read transcript →AKBAAkebia Therapeutics, Inc.May 8, 2023Q1 2023
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 9, 2023Q4 2022
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 3, 2022Q3 2022
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 6, 2022Q2 2022
Read transcript →AKBAAkebia Therapeutics, Inc.May 9, 2022Q1 2022
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 9, 2021Q3 2021
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 5, 2021Q2 2021
Read transcript →AKBAAkebia Therapeutics, Inc.May 10, 2021Q1 2021
Read transcript →AKBAAkebia Therapeutics, Inc.Feb 25, 2021Q4 2020
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 6, 2020Q3 2020
Read transcript →AKBAAkebia Therapeutics, Inc.May 5, 2020Q1 2020
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 10, 2020Q4 2019
Read transcript →AKBAAkebia Therapeutics, Inc.Nov 12, 2019Q3 2019
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 10, 2019Q2 2019
Read transcript →AKBAAkebia Therapeutics, Inc.May 9, 2019Q1 2019
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 18, 2019Q4 2018
Read transcript →AKBAAkebia Therapeutics, Inc.Aug 8, 2018Q2 2018
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 12, 2018Q4 2017
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 6, 2017Q4 2016
Read transcript →AKBAAkebia Therapeutics, Inc.Mar 14, 2016Q4 2015
Read transcript →